SCYNEXIS, Inc. Soared
Fri, Jul 31, 2026 at 07:38 PM
SCYNEXIS, Inc. (SCYX:NASDAQ) jumped higher at $4.84, a gain of 30.5%. On Fri, Jul 31, 2026, SCYX:NASDAQ touched a New 2-Week High of $4.84. The stock appeared on our News Catalysts scanner on Fri, Jul 24, 2026 at 02:43 AM in the 'BIOTECH' category. From Fri, Jul 17, 2026, the stock recorded 50.00% Up Days and 45.45% Green Days
About SCYNEXIS, Inc. (SCYX:NASDAQ)
SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.
Top 10 Gainers:
- Webus International Limited (WETO:NASDAQ), 200%
- Kandal M Venture Limited (FMFC:NASDAQ), 141.41%
- Replimune Group, Inc. (REPL:NASDAQ), 107.02%
- Mangoceuticals, Inc. (MGRX:NASDAQ), 89.75%
- Tucows Inc. (TCX:NASDAQ), 59.18%
- The GrowHub Limited (TGHL:NASDAQ), 53.57%
- Ryde Group Ltd. (RYDE:NYSEMKT), 36.97%
- Concorde International Group Ltd. (CIGL:NASDAQ), 33.14%
- SCYNEXIS, Inc. (SCYX:NASDAQ), 30.46%
- IES Holdings, Inc. (IESC:NASDAQ), 30.27%